Test filters

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

In the media

8 Jul 2026

No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials

The Print

Viewpoints

3 Aug 2026

A new chapter for African medical innovation

Nature Africa

In the media

1 Aug 2026

End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment

Daily Nation

In the media

30 Jul 2026

WHO approves new shorter, less painful Kala-azar treatment for East Africa

New Vision

Viewpoints

30 Jul 2026

Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases

Stat News

Press releases

29 Jul 2026

WHO recommends new, better and safer treatment regimens for leishmaniasis

Press releases

27 Jul 2026

DNDi leadership to change in 2027

Stories

16 Jul 2026

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

Publications

16 Jul 2026

DNDi 2025 Annual Report

In the media

15 Jul 2026

Dengue outbreak complicates Bangladesh measles crisis response

The Telegraph

Press releases

13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security

Press releases

13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Scientific articles

9 Jul 2026

Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring

PLOS Neglected Tropical Diseases

In the media

9 Jul 2026

Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy

The Indian Express

Press Releases Translations

8 Jul 2026

Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia

Press Releases Translations

8 Jul 2026

Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials

A new chapter for African medical innovation

End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment

WHO approves new shorter, less painful Kala-azar treatment for East Africa

Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases

WHO recommends new, better and safer treatment regimens for leishmaniasis

DNDi leadership to change in 2027

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

DNDi 2025 Annual Report

Dengue outbreak complicates Bangladesh measles crisis response

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring

Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy

Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia

Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India

Learn more

Get in touch

Support us

Work with us